Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,001 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, not recruiting

A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

NCT05704049

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Investigational Site Number : 0360002 Wollongong, New South Wales, Australia
  • Investigational Site Number : 0360001 Melbourne, Victoria, Australia
  • Hospital Mae de Deus Site Number : 0760002 Porto Alegre, Rio Grande do Sul, Brazil
  • Clinica São Germano- Site Number : 0760003 São Paulo, Brazil
View all 23 locations
View Trial Details
Active, not recruiting

Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT)

NCT05130827

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Active, not recruiting

A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.

NCT04680052

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • John Muir Health Clinical Research Center Concord, California, United States
  • Marin Cancer Care Greenbrae, California, United States
  • The Oncology Institute of Hope and Innovation Pasadena, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
View all 261 locations
View Trial Details
Active, not recruiting

A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis

NCT05775094

Conditions
Blood Protein Disorders, Bone Diseases, Bone Diseases, Metabolic, +18 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, not recruiting

Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM

NCT04009109

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Northern Light Eastern Maine Medical Center Bangor, Maine, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Active, not recruiting

A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia

NCT03330691

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
  • Seattle Children's Hospital Seattle, Washington, United States
View Trial Details

Related conditions